Síndrome metabólico y complicaciones perioperatorias durante cirugías programadas con anestesia general

Pomares, José; Palomino R, Roberto; Gómez, Claudio J.; Gómez-Camargo, Doris

doi:10.1016/S0120-3347(12)70022-9

Información del artículo

Resumen

Bibliografía

Descargar PDF

Estadísticas

Resumen

Introducción

El síndrome metabólico es un conjunto de alteraciones asociadas a un alto riesgo de enfermedades cardiovasculares. Aunque representa un problema de salud pública, poco se conoce de su impacto en situaciones como la anestésica-quirúrgica.

Objetivo

Analizar la correlación entre síndrome metabólico y complicaciones perioperatorias en pacientes de cirugía programada con anestesia general en Cartagena, Colombia.

Material y métodos

Se diseñó un estudio de casos y controles, con 300 pacientes: 150 casos y 150 controles. Se registraron variables sociodemográficas, hemodinámicas, respiratorias, complicaciones perioperatorias (hipotensión, hipertensión, hipoxemia, sangrado, dolor moderado-severo y náuseas o vómitos postoperatorios). Se emplearon la prueba exacta de Fisher o la de la χ2, según fuera apropiado, para la comparación de grupos. Se aplicó un modelo de regresión logística univariable, para estimar el grado de correlación entre las variables.

Resultados

Las complicaciones perioperatorias fueron más frecuentes en el grupo de casos (p<0,001). Hubo diferencias significativas en edad y estado físico según la Asociación Americana de Anestesiólogos (ASA) (p<0,05). El síndrome metabólico se correlacionó con complicaciones perioperatorias (odds ratio [OR] = 3,31). El estado físico ASA III fue factor de riesgo de complicaciones postoperatorias (OR = 4,01).

Conclusiones

El síndrome metabólico es un factor de riesgo de complicaciones perioperatorias. El estudio indica que hay que implementar estrategias de intervención sanitarias con vistas a la prevención y el manejo del síndrome metabólico en el ámbito quirúrgico, lo que conlleva reducción de las complicaciones perioperatorias asociadas.

Palabras clave:

Resistencia a la insulina

Anestesia general

Enfermedades cardiovasculares

Medicina

Abstract

Introduction

Metabolic syndrome (MS) is a cluster of altertions associated to high risk of cardiovascular diseases and diabetes mellitus. Although MS is a public health issue, little has been studied about its impact in the anesthetic-surgical scene.

Aims

To analyze the correlation level between MS and perioperative complications, in patients under programmed surgery with general anesthesia technique in Cartagena, Colombia.

Materials and methods

A case control study was designed, where 300 patients were enrolled: 150 cases and 150 controls. Socio-demographic, hemodynamics and respiratory variables, as well as surgical complications (hypotension, hypertension, hypoxemia, bleeding, moderated-severe pain and post chirurgical nausea-vomiting) were registered. Fisher's exact test and χ2, where appropriated were employed to compare categorical data. A logistic regression model was applied to calculate correlation between variables.

Results

Surgical complications were more frequent in cases group (P<.001). Differences in age and ASA physical status were also found (P<.05). MS was correlated to perioperative complications (OR: 3.31; P<.05). ASA III physical status was another risk factor to post surgical complications development (OR: 4.01; P<.05). None mortality case was reported.

Conclusions

In a comparison with healthy population, MS represented a risk factor to perioperative complications development. According to results, further prevention and approach guidelines in order to reduce perioperative complications associated to MS.

Keywords:

Insulin resistance

General anesthesia

Medicine

Cardiovascular diseases

El Texto completo está disponible en PDF

Referencias

[1.]

H.P. Himsworth.

Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types.

Lancet, 127 (1936), pp. 127-130

[2.]

B. Mlinar, J. Marc, A. Janež, M. Pfeifer.

Molecular mechanisms of insulin resistance and associated diseases.

Clin Chim Acta, 375 (2007), pp. 20-35

http://dx.doi.org/10.1016/j.cca.2006.07.005 | Medline

[3.]

G.D. Wells, M.D. Noseworthy, J. Hamilton, M. Tarnopolski, I. Tein.

Skeletal muscle metabolic dysfunction in obesity and metabolic syndrome.

Can J Neurol Sci, 35 (2008), pp. 31-40

Medline

[4.]

K.F. Kuchta.

Pathophysiologic changes of obesity.

Anesthesiol Clin North Am, 23 (2005), pp. 421-429

[5.]

L. Pradilla Suarez, P. Lopez Jaramillo, Y.T. Bracho.

Papel del adipocito en la inflamación del síndrome metabólico.

Acta Médica Colombiana, 30 (2005), pp. 137-140

[6.]

S.M. Grundy, J.I. Cleeman.

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary.

Circulation, 112 (2005), pp. e285-e290

[7.]

K.G.M.M. Alberti, P. Zimmet, J. Shaw.

Metabolic syndrome —A new world-wide definition, a consensus statement from the International Diabetes Federation.

Diabet Med, 23 (2006), pp. 469-480

http://dx.doi.org/10.1111/j.1464-5491.2006.01858.x | Medline

[8.]

R. Garcia Gomez, A. Cifuentes, R. Caballero, L. Sanchez, P. Lopez Jaramillo.

A proposal for an appropriate central obesity diagnosis in Latin American population.

Int J Cardiol, 110 (2006), pp. 263-264

http://dx.doi.org/10.1016/j.ijcard.2005.08.017 | Medline

[9.]

G.M. Reaven.

Banting lecture 1988. Role of insulin resistance in human disease.

Diabetes, 37 (1988), pp. 1595-1607

Medline

[10.]

D. Einhorn, G.M. Reaven, R.H. Cobin, E. Ford, O.P. Ganda, Y. Handelsman, et al.

American Association of Clinical Endocrinology position statement on insulin resistance syndrome.

Endocr Pract, 9 (2003), pp. 237-252

Medline

[11.]

K.G. Alberti, P.Z. Zimmet.

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Diabet Med, 15 (1998), pp. 539-553

http://dx.doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S | Medline

[12.]

National Institutes of Health.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report.

Circulation, 106 (2002), pp. 3143

Medline

[13.]

G. Seematter, C. Binnert, L. Tappy.

Stress and metabolism.

Metab Syndr Relat Disord, 3 (2005), pp. 8-13

http://dx.doi.org/10.1089/met.2005.3.8 | Medline

[14.]

B.M. Biccard.

A peri-operative statin update for non-cardiac surgery. Part I: The effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients.

Anaesthesia, 63 (2008), pp. 52-64

http://dx.doi.org/10.1111/j.1365-2044.2007.05264.x | Medline

[15.]

D.M. Whelan, R.C. Roy.

Diseases of aging that emerge from the metabolic syndrome.

Anesthesiol Clin, 24 (2006), pp. 599-619

Medline

[16.]

K.F. Kuchta.

Pathophysiologic changes of obesity.

Anesthesiol Clin North Am, 23 (2005), pp. 421-429

[17.]

G. Seematter, C. Binnert, J.L. Martin, L. Tappy.

Relationship between stress, inflammation and metabolism.

Curr Opin Clin Nutr Metab Care, 7 (2004), pp. 169-173

Medline

[18.]

F. Donatelli, P. Cavagna, G. Di Dedda, A. Catenacci, M. Di Nicola, L. Lorini, et al.

Correlation between pre-operative metabolic syndrome and persistent blood glucose elevation during cardiac surgery in non-diabetic patients.

Acta Anaesthesiol Scand, 52 (2008), pp. 1103-1110

http://dx.doi.org/10.1111/j.1399-6576.2008.01693.x | Medline

[19.]

ASA Relative Value Guide. American Society of Anesthesiologists; 2002. p. XII.

[20.]

A.S. Keats.

The ASA Clasification of physical status —a recapitulation.

Anesthesiology, 49 (1978), pp. 233

Medline

[21.]

Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery.

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Circulation, 116 (2007), pp. 1971-1996

http://dx.doi.org/10.1161/CIRCULATIONAHA.107.185700 | Medline

[22.]

J.C. Botero, D. Salazar, O. Cortez.

Metabolic syndrome and cardiovascular risk.

Rev CES Med, 20 (2006), pp. 73-81

[23.]

J. Escobedo, H. Schargrodsky, B. Champagne, H. Silva, C.P. Boissonnet, R. Vinueza, et al.

Prevalence of the metabolic syndrome in Latin America and its association with subclinical carotid atherosclerosis: the CARMELA cross sectional study.

Cardiovasc Diabetol, 8 (2009), pp. 52

http://dx.doi.org/10.1186/1475-2840-8-52 | Medline

[24.]

Resolución 2378 de junio 27 de 2008 del Ministerio de Protección Social [citado Jul 2010]. Disponible en: http://mps.minproteccionsocial.gov.co/vbecontent/NewsDetail.asp?ID=17866.

[25.]

L. Elizondo-Montemayor, M. Serrano-González, P.A. Ugalde-Casas, H. Bustamante-Careaga, C. Cuello-García.

Waist-to-Height: Cutoff Matters in Predicting Metabolic Syndrome in Mexican Children.

Metab Syndr Relat Disord, (2011),

[26.]

W. Liu, R. Lin, A. Liu, L. Du, Q. Chen.

Prevalence and association between obesity and metabolic syndrome among Chinese elementary school children: a school-based survey.

BMC Public Health, 10 (2010), pp. 780

http://dx.doi.org/10.1186/1471-2458-10-780 | Medline

[27.]

Campillo Acosta D, Berdasquera Corcho D, Coronado Mestre R. Mortalidad asociada al síndrome metabólico. Rev Cubana Med Gen Integr. 2007; 23:[citado mayo 2011]. Disponible en http://bvs.sld.cu/revistas/mgi/vol23207/mgi03207.htm.

[28.]

E. Alegría, A. Cordero, J.A. Casanovas.

Prevalencia del síndrome metabólico en población laboral española.

Rev Esp Cardiol, 58 (2005), pp. 797-806

Medline

[29.]

P. López-Jaramillo, S. Silva, F. Ramírez, R. García.

Síndrome metabólico: diagnóstico y prevención.

Acta Med Colomb, 29 (2004), pp. 137-144

[30.]

B. Isoma, P. Alegren, T. Toumi, B. Forsen, K. Latí, M. Nissen, et al.

Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Diabetes Care, 24 (2001), pp. 683-689

Medline

[31.]

D.M. Greer, D.C. Hill.

Implementing an evidence-based metabolic syndrome prevention and treatment program utilizing group visits.

J Am Acad Nurse Pract, 23 (2011), pp. 76-83

http://dx.doi.org/10.1111/j.1745-7599.2010.00585.x | Medline

[32.]

D. Enrique-Santos.

Fisiopatología de la respuesta inflamatoria durante el perioperatorio.

Rev Mex Anestesiol, 30 (2007), pp. S157-S159

[33.]

W. Aekplakorn, V. Chongsuvivatwong, P. Tatsanavivat, P. Suriyawongpaisal.

Prevalence of metabolic syndrome defined by the International Diabetes Federation and National Cholesterol Education Program criteria among Thai adults.

Asia Pac J Public Health, 23 (2011), pp. 792-800

http://dx.doi.org/10.1177/1010539511424482 | Medline

[34.]

A.C. Sinha.

Some anesthetic aspects of morbid obesity.

Curr Opin Anaesthesiol, 22 (2009), pp. 442-446

http://dx.doi.org/10.1097/ACO.0b013e32832b6807 | Medline

[35.]

P.J. Neligan.

Metabolic syndrome: anesthesia for morbid obesity.

Curr Opin Anaesthesiol, 23 (2010), pp. 375-383

Medline